719
Views
12
CrossRef citations to date
0
Altmetric
Laboratory Study

Lysophosphatidic Acid and Lovastatin Might Protect Kidney in Renal I/R Injury by Downregulating MCP-1 in Rat

, , , , &
Pages 805-810 | Received 05 Mar 2011, Accepted 15 Jun 2011, Published online: 04 Aug 2011

REFERENCES

  • Agrawal M, Swartz R. Acute renal failure. Am Fam Physician. 2000;61:2077–2088.
  • Chao IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610–621.
  • Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Hemost. 2007;97:738–747.
  • Jassem W, Fuggle SV, Rela M, Koo DD, Heaton ND. The role of mitochondria in ischemia/reperfusion injury. Transplantation. 2002;73:493–499.
  • Daemen MA, de Vries B, Buurman WA. Apoptosis and inflammation in renal reperfusion injury. Transplantation. 2002;73:1693–1700.
  • Duque N, Gomez-Guerrero C, Egido J. Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol. 1997;159:3474–3482.
  • Kakio T, Matsumori A, Ono K, Ito H, Matsushima K, Sasayama S. Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart. Lab Invest. 2000;80:1127–1136.
  • Stroo I, Stokman G, Teske GJ, . Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int Immunol. 2010;22:433–442.
  • Furuichi K, Wada T, Iwata Y, . CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol. 2003;14:2503–2515.
  • Furuichi K, Wada T, Iwata Y, . Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol. 2003;14:1066–1071.
  • de Vries B, Matthijsen RA, van Bijnen AA, Wolfs TG, Buurman WA. Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol. 2003;163:47–56.
  • Thurman JM, Lenderink AM, Royer PA, . C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. J Immunol. 2007;178:1819–1828.
  • Yuzbasioglu MF, Aykas A, Kurutas EB, Sahinkanat T. Protective effects of propofol against ischemia/reperfusion injury in rat kidneys. Ren Fail. 2010;32:578–583.
  • Fouad AA, Qureshi HA, Al-Sultan Al, Yacoubi MT, Al-Melhim WN. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury. Pharmacology. 2010;85:158–167.
  • Horvath G, Racz B, Reglodi D, . Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion. J Mol Neurosci. 2010;42:411–418.
  • Semedo P, Wang PM, Andreucci TH, . Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplant Proc. 2007;39:421–423.
  • Zhuo W, Liao L, Xu T, Wu W, Yang S, Tan J. Mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal dysfunction by improving the antioxidant/oxidant balance in the ischemic kidney. Urol Int. 2010;82(6):191–196; doi:10.1159/000319366.
  • Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL, Duffield JS. Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation. 2010;121:2211–2220.
  • Pisani A, Uccello F, Cesaro A, . Effects of atorvastatin on ischemic acute renal failure in aging rats. G Ital Nefrol. 2002;19:534–539.
  • Zoja C, Corna D, Rottoli D, . Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Kindey Int. 2002;61:1635–1645.
  • Lu JX, Ping JG, Yan CY. Establish of rat model of renal cold ischemia-reperfusion injury. Chin J Hemorheol. 2005;15:45–47.
  • Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984;74:1156–1164.
  • Contos JJ, Ishii I, Chun J. Lysophosphatidic acid receptors. Mol Pharmacol. 2000;58:1188–1196.
  • Balazs L, Okolicany J, Ferrebee M, Tolley B, Tigyi G. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am J Physiol Regul Integr Comp Physiol. 2001;280:R466–R472.
  • Inoue CN. LPA as a determinant of mesangial growth and apoptosis. Semin Nephrol. 2002;22:415–422.
  • Chen X, Yang XY, Wang ND, . Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction. Scand J Clin Lab Invest. 2003;63:497–503.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.